Metachronous and synchronous primary lung cancers: Diagnostic aspects, surgical treatment, and prognosis

Clinical Lung Cancer

Volumn 16, Issue 1, 2015, Pages 15-23

  Loukeri, Angeliki A ^a   Kampolis, Christos F ^b   Ntokou, Anna ^a   Tsoukalas, George ^a   Syrigos, Konstantinos ^a  

^a SOTIRIA GENERAL HOSPITAL   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

Author keywords

Diagnosis; Management; Multiple lung cancers; Second tumor; Survival

Indexed keywords

CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER PATIENT; CANCER PROGNOSIS; CANCER SURGERY; CANCER THERAPY; DISEASE SURVEILLANCE; FEASIBILITY STUDY; HUMAN; LUNG CANCER; LUNG METASTASIS; PATHOGENESIS; PATHOLOGY; PRIMARY TUMOR; REVIEW; SECOND CANCER; STEREOTACTIC BODY RADIATION THERAPY; SURGICAL APPROACH; SURGICAL TECHNIQUE; CARCINOMA, NON-SMALL-CELL LUNG; DIFFERENTIAL DIAGNOSIS; LUNG NEOPLASMS; METASTASIS; MOLECULAR PATHOLOGY; NEOPLASMS, MULTIPLE PRIMARY; NEOPLASMS, SECOND PRIMARY; PROGNOSIS; SMALL CELL LUNG CARCINOMA; THORAX SURGERY;

CARCINOMA, NON-SMALL-CELL LUNG; DIAGNOSIS, DIFFERENTIAL; HUMANS; LUNG NEOPLASMS; NEOPLASM METASTASIS; NEOPLASMS, MULTIPLE PRIMARY; NEOPLASMS, SECOND PRIMARY; PATHOLOGY, MOLECULAR; PROGNOSIS; SMALL CELL LUNG CARCINOMA; THORACIC SURGICAL PROCEDURES;

EID: 84927509297     PISSN: 15257304     EISSN: 19380690     Source Type: Journal    
DOI: 10.1016/j.cllc.2014.07.001     Document Type: Review

References (93)

1. A. Jemal, F. Bray, and M.M. Center Global cancer statistics CA Cancer J Clin 61 2011 69 90
2. National Cancer Institute. Surveillance, Epidemiology, and End Results Program. SEER Cancer Statistics Review 1975-2009 (Vintage 2009 Populations). Available at: http://seer.cancer.gov/csr/1975-2009-pops09/. Accessed: September 28, 2014.
3. B.E. Johnson Second lung cancers in patients after treatment for an initial lung cancer J Natl Cancer Inst 90 1998 1335 1345
4. A. Warth, S. Macher-Goeppinger, and T. Muley Clonality of multifocal non-small-cell lung cancer: implications for staging and therapy Eur Respir J 39 2012 1437 1442
5. H. Beyreuther Multiplicität von Carcinomen bei einem Fall von sog. "Schneeberger" Lungenkrebs mit Tuberkulose (in German) Virchows Arch 250 1924 230 243
6. N. Martini, and M.R. Melamed Multiple primary lung cancers J Thorac Cardiovasc Surg 70 1975 606 612
7. T. Antakli, R.F. Schaefer, and J.E. Rutherford Second primary lung cancer Ann Thorac Surg 59 1995 863 866
8. K.R. Shen, B.F. Meyers, and J.M. Larner Special treatment issues in lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition) Chest 132 2007 290S 305S
9. C. Deschamps, P.C. Pairolero, and V.F. Trastek Multiple primary lung cancers. Results of surgical treatment J Thorac Cardiovasc Surg 99 1990 769 777
10. T.K. Rosengart, N. Martini, and P. Ghosn Multiple primary lung carcinomas: prognosis and treatment Ann Thorac Surg 52 1991 773 778
11. L.P. Faber Resection for second and third primary lung cancer Semin Surg Oncol 9 1993 135 141
12. A. Sulkes, Y. Naparstek, and M. Shalit Second primary lung carcinoma J Surg Oncol 15 1980 375 380
13. S.A. Adebonojo, D.M. Moritz, and C.A. Danby The results of modern surgical therapy for multiple primary lung cancers Chest 112 1997 693 701
14. M. Okada, N. Tsubota, and M. Yoshimura Operative approach for multiple primary lung carcinomas J Thorac Cardiovasc Surg 115 1998 836 840
15. L. Voltolini, P. Paladini, and L. Luzzi Iterative surgical resections for local recurrent and second primary bronchogenic carcinoma Eur J Cardiothorac Surg 18 2000 529 534
16. J.W. Asaph, J.F. Keppel, and J.R. Handy Surgery for second lung cancers Chest 118 2000 1621 1625
17. M.T. Van Rens, P. Zanen, and A.B. de la Rivière Survival after resection of metachronous non-small-cell lung cancer in 127 patients Ann Thorac Surg 71 2001 309 313
18. F. Rea, A. Zuin, and D. Callegaro Surgical results for multiple primary lung cancers Eur J Cardiothorac Surg 20 2001 489 495
19. T.M. Aziz, R.A. Saad, and J. Glasser The management of second primary lung cancers. A single centre experience in 15 years Eur J Cardiothorac Surg 21 2002 527 533
20. D. Rice, H.W. Kim, and A. Sabichi The risk of second primary tumors after resection of stage I non-small-cell lung cancer Ann Thorac Surg 76 2003 1001 1007
21. R.J. Battafarano, S.D. Force, and B.F. Meyers Benefits of resection for metachronous lung cancer J Thorac Cardiovasc Surg 127 2004 836 842
22. Y.L. Chang, C.T. Wu, and Y.C. Lee Surgical treatment of synchronous multiple primary lung cancers: experience of 92 patients J Thorac Cardiovasc Surg 134 2007 630 637
23. H. Rostad, T.E. Strand, and A. Naalsund Resected synchronous primary malignant lung tumors: a population-based study Ann Thorac Surg 85 2008 204 209
24. M. Riquet, A. Cazes, and K. Pfeuty Multiple lung cancers prognosis: what about histology? Ann Thorac Surg 86 2008 921 926
25. L. Voltolini, C. Rapicetta, and L. Luzzi Surgical treatment of synchronous multiple lung cancer located in a different lobe or lung: high survival in node-negative subgroup Eur J Cardiothorac Surg 37 2010 1198 1204
26. C.I. Kocaturk, M.Z. Gunluoglu, and L. Cansever Survival and prognostic factors in surgically resected synchronous multiple primary lung cancers Eur J Cardiothorac Surg 39 2011 160 166
27. S. Haraguchi, K. Koizumi, and T. Hirata Surgical treatment of metachronous non-small-cell lung cancer Ann Thorac Cardiovasc Surg 16 2010 319 325
28. M.K. Bae, C.S. Byun, and C.Y. Lee The role of surgical treatment in second primary lung cancer Ann Thorac Surg 92 2011 256 262
29. T. Ishigaki, T. Yoshimasu, and S. Oura Surgical treatment for metachronous second primary lung cancer after radical resection of primary lung cancer Ann Thorac Cardiovasc Surg 19 2013 341 344
30. G.L. Colice, J. Rubins, and M. Unger Follow-up and surveillance of the lung cancer patient following curative-intent therapy Chest 123 suppl 1 2003 272S 283S
31. W.D. Travis, E. Brambilla, and M. Noguchi International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society international multidisciplinary classification of lung adenocarcinoma J Thorac Oncol 6 2011 244 285
32. N. Girard, C. Deshpande, and C. Lau Comprehensive histologic assessment helps to differentiate multiple lung primary non-small-cell carcinomas from metastases Am J Surg Pathol 33 2009 1752 1764
33. D.P. Slaughter, H.W. Southwick, and W. Smejkal Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin Cancer 6 1953 963 968
34. O. Auerbach, A.P. Stout, E.C. Hammond, and L. Garfinkel Changes in bronchial epithelium in relation to cigarette smoking and in relation to lung cancer N Engl J Med 265 1961 253 267
35. S.K. Sikkink, T. Liloglou, and P. Maloney In-depth analysis of molecular alterations within normal and tumor tissue from an entire bronchial tree Int J Oncol 22 2003 589 595
36. M.A. Tucker, N. Murray, and E.G. Shaw Second primary cancers related to smoking and treatment of small cell lung cancer. Lung Cancer Working Cadre J Natl Cancer Inst 89 1997 1782 1788
37. R.A. Smith, B.K. Nigam, and J.M. Thompson Second primary lung carcinoma Thorax 31 1976 507 516
38. J. Huang, C. Behrens, and I. Wistuba Molecular analysis of synchronous and meta-chronous tumors of the lung: impact on management and prognosis Ann Diagn Pathol 5 2001 321 329
39. T. Mitsudomi, Y. Yatabe, and T. Koshikawa Mutations of the P53 tumor suppressor gene as clonal marker for multiple primary lung cancers J Thorac Cardiovasc Surg 114 1997 354 360
40. M.T. Van Rens, E.J. Eijken, and J.R. Elbers p53 mutation analysis for definite diagnosis of multiple primary lung carcinoma Cancer 94 2002 188 196
41. N. Girard, I. Ostrovnaya, and C. Lau Genomic and mutational profiling to assess clonal relationships between multiple non-small-cell lung cancers Clin Cancer Res 15 2009 5184 5190
42. J.S. Wainscoat, and M.F. Fey Assessment of clonality in human tumors: a review Cancer Res 50 1990 1355 1360
43. S. Shimizu, Y. Yatabe, and T. Koshikawa High frequency of clonally related tumors in cases of multiple synchronous lung cancers as revealed by molecular diagnosis Clin Cancer Res 6 2000 3994 3999
44. K. Hiroshima, T. Toyozaki, and H. Kohno Synchronous and metachronous lung carcinomas: molecular evidence for multicentricity Pathol Int 48 1998 869 876
45. A.F. Gazdar The molecular and cellular basis of human lung cancer Anticancer Res 14 1994 261 267
46. B. Passlick, J.R. Izbicki, and G. Riethmüller p53 in non-small-cell lung cancer J Natl Cancer Inst 86 1994 801 803
47. M.S. Greenblatt, W.P. Bennett, and M. Hollstein Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis Cancer Res 54 1994 4855 4878
48. K.Y. Chung, T. Mukhopadhyay, and J. Kim Discordant p53 gene mutations in primary head and neck cancers and corresponding second primary cancers of the upper aerodigestive tract Cancer Res 53 1993 1676 1683
49. M. Noguchi, N. Maezawa, and Y. Nakanishi Application of the p53 gene mutation pattern for differential diagnosis of primary versus metastatic lung carcinomas Diagn Mol Pathol 2 1993 29 35
50. G. Sozzi, M. Miozzo, and U. Pastorino Genetic evidence for an independent origin of multiple preneoplastic and neoplastic lung lesions Cancer Res 55 1995 135 140
51. D. Matsuzoe, T. Hideshima, and K. Ohshima Discrimination of double primary lung cancer from intrapulmonary metastasis by p53 gene mutation Br J Cancer 79 1999 1549 1552
52. H. Sakamoto, J. Shimizu, and Y. Horio Disproportionate representation of KRAS gene mutation in atypical adenomatous hyperplasia, but even distribution of EGFR gene mutation from preinvasive to invasive adenocarcinomas J Pathol 212 2007 287 294
53. G. Sartori, A. Cavazza, and F. Bertolini A subset of lung adenocarcinomas and atypical adenomatous hyperplasia-associated foci are genotypically related: an EGFR, HER2, and K-ras mutational analysis Am J Clin Pathol 129 2008 202 210
54. Y.L. Chang, C.T. Wu, and S.C. Lin Clonality and prognostic implications of p53 and epidermal growth factor receptor somatic aberrations in multiple primary lung cancers Clin Cancer Res 13 2007 52 58
55. K. Takamochi, S. Oh, and J. Matsuoka Clonality status of multifocal lung adenocarcinomas based on the mutation patterns of EGFR and K-ras Lung Cancer 75 2012 313 320
56. X. Wang, M. Wang, and G.T. MacLennan Evidence for common clonal origin of multifocal lung cancers J Natl Cancer Inst 101 2009 560 570
57. A.G. Knudson Mutation and cancer: statistical study of retinoblastoma Proc Natl Acad Sci U S A 68 1971 820 823
58. X. Mao, B.D. Young, and Y.J. Lu The application of single nucleotide polymorphism microarrays in cancer research Curr Genomics 8 2007 219 228
59. C.V. Wa, S. DeVries, and Y.Y. Chen Clinical application of array-based comparative genomic hybridization to define the relationship between multiple synchronous tumors Mod Pathol 18 2005 591 597
60. M.A. Bollet, N. Servant, and P. Neuvial High-resolution mapping of DNA breakpoints to define true recurrences among ipsilateral breast cancers J Natl Cancer Inst 100 2008 48 58
61. J. Arai, T. Tsuchiya, and M. Oikawa Clinical and molecular analysis of synchronous double lung cancers Lung Cancer 77 2012 281 287
62. M. Gerlinger, A.J. Rowan, and S. Horswell Intratumor heterogeneity and branched evolution revealed by multiregion sequencing N Engl J Med 366 2012 883 892
63. A. Hata, S. Fujita, and R. Kaji Do complex mutations of the epidermal growth factor receptor gene reflect intratumoral heterogeneity? J Thorac Oncol 6 2011 1144 1146
64. T.J. Grob, I. Kannengiesser, and M.C. Tsourlakis Heterogeneity of ERBB2 amplification in adenocarcinoma, squamous cell carcinoma and large cell undifferentiated carcinoma of the lung Mod Pathol 25 2012 1566 1573
65. T.J. Grob, T. Hoenig, and T.S. Clauditz Frequent intratumoral heterogeneity of EGFR gene copy gain in non-small-cell lung cancer Lung Cancer 79 2013 221 227
66. H. Bai, Z. Wang, and Y. Wang Detection and clinical significance of intratumoral EGFR mutational heterogeneity in Chinese patients with advanced non-small-cell lung cancer PLoS One 8 2013 e54170
67. X. Xue, Q. Xue, and N. Wang Early clinical diagnosis of synchronous multiple primary lung cancer Oncol Lett 3 2012 234 237
68. B.D. Kozower, J.M. Larner, and F.C. Detterbeck Special treatment issues in non-small-cell lung cancer. Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines Chest 143 suppl 5 2013 e369S e399S
69. D.J. Mathisen, R.J. Jensik, and L.P. Faber Survival following resection for second and third primary lung cancers J Thorac Cardiovasc Surg 88 1984 502 510
70. R.J. Jensik, L.P. Faber, and C.F. Kittle Survival following resection for second primary bronchogenic carcinoma J Thorac Cardiovasc Surg 82 1981 658 668
71. R.J. Ginsberg, and L.V. Rubinstein Randomized trial of lobectomy versus limited resection for T1 N0 non-small-cell lung cancer. Lung Cancer Study Group Ann Thorac Surg 60 1995 615 622
72. M. Nakata, S. Sawada, and M. Yamashita Surgical treatments for multiple primary adenocarcinoma of the lung Ann Thorac Surg 78 2004 1194 1199
73. H. Onishi, H. Shirato, and Y. Nagata Stereotactic body radiotherapy (SBRT) for operable stage I non-small-cell lung cancer: can SBRT be comparable to surgery? Int J Radiat Oncol Biol Phys 81 2011 1352 1358
74. I.S. Grills, V.S. Mangona, and R. Welsh Outcomes after stereotactic lung radiotherapy or wedge resection for stage I non-small-cell lung cancer J Clin Oncol 28 2010 928 935
75. T.D. Crabtree, C.E. Denlinger, and B.F. Meyers Stereotactic body radiation therapy versus surgical resection for stage I non-small-cell lung cancer J Thorac Cardiovasc Surg 140 2010 377 386
76. S.M. Shirvani, J. Jiang, and J.Y. Chang Comparative effectiveness of 5 treatment strategies for early stage non-small-cell lung cancer in the elderly Int J Radiat Oncol Biol Phys 84 2012 1060 1070
77. J.Y. Chang, Y.H. Liu, and Z. Zhu Stereotactic ablative radiotherapy: a potentially curable approach to early stage multiple primary lung cancer Cancer 119 2013 3402 3410
78. F.J. Lagerwaard, N.E. Verstegen, and C.J. Haasbeek Outcomes of stereotactic ablative radiotherapy in patients with potentially operable stage I non-small-cell lung cancer Int J Radiat Oncol Biol Phys 83 2012 348 353
79. J.M. Varlotto, A.J. Fakiris, and J.C. Flickinger Matched-pair and propensity score comparisons of outcomes of patients with clinical stage I non-small cell lung cancer treated with resection or stereotactic radiosurgery Cancer 119 2013 2683 2691
80. K.M. Creach, J.D. Bradley, and P. Mahasittiwat Stereotactic body radiation therapy in the treatment of multiple primary lung cancers Radiother Oncol 104 2012 19 22
81. G.H. Griffioen, F.J. Lagerwaard, and C.J. Haasbeek Treatment of multiple primary lung cancers using stereotactic radiotherapy, either with or without surgery Radiother Oncol 107 2013 403 408
82. C.A. Ridge, M. Silk, and E.N. Petre Radiofrequency ablation of T1 lung carcinoma: comparison of outcomes for first primary, metachronous and synchronous lung tumors J Vasc Interv Radiol 25 2014 989 996
83. P.C. Pairolero, D.E. Williams, and E.J. Bergstralh Postsurgical stage I bronchogenic carcinoma: morbid implications of recurrent disease Ann Thorac Surg 38 1984 331 338
84. A.F. Verhagen, G. Tavilla, and H.J. van de Wal Multiple primary lung cancers Thorac Cardiovasc Surg 42 1994 40 44
85. B.E. Lee, J.L. Port, and B.M. Stiles TNM stage is the most important determinant of survival in metachronous lung cancer Ann Thorac Surg 88 2009 1100 1105
86. C.F. Mountain Revisions in the International System for Staging Lung Cancer Chest 111 1997 1710 1717
87. J.F. Vansteenkiste, B. De Belie, and G.J. Deneffe Practical approach to patients presenting with multiple synchronous suspect lung lesions: a reflection on the current TNM classification based on 54 cases with complete follow-up Lung Cancer 34 2001 169 175
88. T.E. Strand, H. Rostad, and B. Møller Survival after resection for primary lung cancer: a population based study of 3211 resected patients Thorax 61 2006 710 715
89. A.S. Bryant, S.J. Pereira, and D.L. Miller Satellite pulmonary nodule in the same lobe (T4N0) should not be staged as IIIB non-small-cell lung cancer Ann Thorac Surg 82 2006 1808 1813
90. M. Okada, N. Tsubota, and M. Yoshimura Evaluation of TMN classification for lung carcinoma with ipsilateral intrapulmonary metastasis Ann Thorac Surg 68 1999 326 330
91. J. Rubins, M. Unger, G.L. Colice, and American College of Chest Physicians Follow-up and surveillance of the lung cancer patient following curative intent therapy: ACCP evidence-based clinical practice guideline (2nd edition) Chest 132 suppl 3 2007 355S 367S
92. D.S. Ettinger, W. Akerley, and H. Borghaei Non-small-cell lung cancer J Natl Compr Canc Netw 10 2012 1236 1271
93. Clinical practice guidelines for the treatment of unresectable non-small-cell lung cancer. Adopted on May 16, 1997 by the American Society of Clinical Oncology J Clin Oncol 15 1997 2996 3018